These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. Falagas ME; Kasiakou SK; Michalopoulos A J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070 [No Abstract] [Full Text] [Related]
9. Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria. Athanassa ZE; Myrianthefs PM; Boutzouka EG; Tsakris A; Baltopoulos GJ J Hosp Infect; 2011 Aug; 78(4):335-6. PubMed ID: 21641678 [No Abstract] [Full Text] [Related]
10. [Shedding light on the use of colistin: still gaps to be filled]. Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335 [TBL] [Abstract][Full Text] [Related]
11. Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin. Valour F; Dutronc H; Dinh A; Cazorla C; Pavèse P; Lesens O; Uçkay I; Chidiac C; Ferry T; Int J Antimicrob Agents; 2013 Feb; 41(2):197-9. PubMed ID: 23146203 [No Abstract] [Full Text] [Related]
13. Intravenous colistin administration in neonates. Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777 [TBL] [Abstract][Full Text] [Related]
14. Colistin pharmacokinetics: the fog is lifting. Couet W; Grégoire N; Marchand S; Mimoz O Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293 [TBL] [Abstract][Full Text] [Related]
16. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Falagas ME; Rafailidis PI; Kasiakou SK; Hatzopoulou P; Michalopoulos A Clin Microbiol Infect; 2006 Dec; 12(12):1227-30. PubMed ID: 17121631 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842 [TBL] [Abstract][Full Text] [Related]
19. Returning to the pre-antibiotic era in the critically ill: the XDR problem. Paterson DL; Lipman J Crit Care Med; 2007 Jul; 35(7):1789-91. PubMed ID: 17581370 [No Abstract] [Full Text] [Related]
20. Use of colistin in children. Tamma PD; Lee CK Pediatr Infect Dis J; 2009 Jun; 28(6):534-5. PubMed ID: 19483519 [No Abstract] [Full Text] [Related] [Next] [New Search]